Center for Integrated and Novel Approaches in Vascular-Metabolic Disease

The need for integrated cardiovascular-metabolic care

The highest quality care of patients with obesity and diabetes necessitates a multidisciplinary team approach and requires a far greater degree of collaboration than other diseases. The chronicity of these health problems, complexity of diagnosis and treatment, and traditional siloes of various specialists results in delayed, fragmented and high-cost care delivery that begs for an alternate model. The treatment of cardiovascular complications of metabolic disorders typified by type 2 diabetes is at the top of health care spending and at the heart of the near-term health care affordability crisis. One of the barriers has been the failure to intervene in early disease.

A New Approach

University Hospitals Harrington Heart & Vascular Institute has established the novel Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA), which brings together multiple University Hospitals disciplines in a unique platform to advance the understanding and treatment of cardiac and vascular complications of metabolic disease. UH CINEMA leverages existing system partnerships, resources and investments, and builds on years of collaborative experience among UH principal investigators and clinical care providers.

UH CINEMA’s focus is at the intersection of vascular disease, type 2 diabetes and obesity. Given that the major consequence of metabolic disorders are cardiovascular complications such as coronary, cerebrovascular and peripheral artery disease, these are necessarily a priority for the team. However, other rare metabolic diseases with vascular manifestations with scope for cure are also included in the center.

Referred patients have a single appointment health assessment to review questions about their metabolic condition (diabetes), along with screening for kidney disease, heart disease and related risk factor management (blood pressure, cholesterol and triglycerides, smoking, diet and exercise). Multiple specialists then review the assessment and share combined treatment recommendations to lower potential risk for diabetes-related heart and kidney complications.

 

 

Cardiometabolic Risk Factors

Metabolic Risk Factors

Abdominal obesity
Diabetes mellitus
Hyperglycemia
Hypertriglyceridemia

Non-Traditional Cardiovascular Risk Factors

Genetic profile
Inflammatory disease
Prothrombotic state

Traditional Cardiovascular Risk Factors

Age
Family history
Gender
Hyperlipidemia
Hypertension
Smoking

Strong Scientific Leadership

UH CINEMA includes some of the world’s foremost experts in clinical care of diabetics with cardiovascular complications, prevention and therapy of vascular-metabolic disease, translational research and implementation science.

Back to Top